These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 24508069)

  • 1. Long noncoding RNA: "LNCs" to cancer.
    Sültmann H; Diederichs S
    Eur Urol; 2014 Jun; 65(6):1152-3. PubMed ID: 24508069
    [No Abstract]   [Full Text] [Related]  

  • 2. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
    Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
    Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
    Su YJ; Yu J; Huang YQ; Yang J
    Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: Risk SNPs modulate lncRNAs.
    Stone L
    Nat Rev Urol; 2016 Oct; 13(10):565. PubMed ID: 27578041
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers.
    Tortora F; La Civita E; Trivedi P; Febbraio F; Terracciano D; Cimmino A
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
    Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
    Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C; Guo Y; Zhang H; Xue YX
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.
    Terracciano D; Ferro M; Terreri S; Lucarelli G; D'Elia C; Musi G; de Cobelli O; Mirone V; Cimmino A
    Transl Res; 2017 Jun; 184():108-117. PubMed ID: 28438520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going viral? Linking the etiology of human prostate cancer to the
    Teixeira AA; Marchiò S; Dias-Neto E; Nunes DN; da Silva IT; Chackerian B; Barry M; Lauer RC; Giordano RJ; Sidman RL; Wheeler CM; Cavenee WK; Pasqualini R; Arap W
    EMBO Mol Med; 2017 Oct; 9(10):1327-1330. PubMed ID: 28751581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs as biomarkers for metastatic prostate cancer.
    Veltri WR
    Lancet Oncol; 2014 Dec; 15(13):1412-1413. PubMed ID: 25456354
    [No Abstract]   [Full Text] [Related]  

  • 13. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    Schubert M; Junker K; Heinzelmann J
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
    Zhu Z; Xu L; Wan Y; Zhou J; Fu D; Chao H; Bao K; Zeng T
    Cancer Biomark; 2018; 22(2):275-281. PubMed ID: 29614625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.